-
INTERNATIONAL CONGRESS on RESEARCH of …
29 February – 2 March, 2012
Gebert Rüf Stiftung and BLACKSWAN Foundation, both active in supporting …
-
Second ASID Congress of the African …
8–11 March, 2012
-
Human Genome Meeting – Genetics and …
11–14 March, 2012
WelcomeProfessor Edison LiuPresident, Human Genome Organisation HGM 2012I …
-
The 2nd National Conference on Blood …
12–14 March, 2012
The Division of Blood Disorders, National Center on Birth Defects and …
Events
-
When the Isolated Lung Runs Out of Air
Sunday, February 5, 2012
MUNICH, Germany - For patients with incurable pulmonary conditions, a lung transplantation is the only available treatment option. However, suitable donor organs are scarce, and even getting them to prospective recipients is not easyAs Professor Alexander Dietrich of the Walther Straub Institute o
-
Rituximab Possible Treatment Option for Patients With Primary Biliary Cirrhosis
Sunday, February 5, 2012
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, also known as Ursodiol. Study details available in the February issue of
-
Coffee Consumption Reduces Fibrosis Risk in Those With Fatty Liver Disease
Sunday, February 5, 2012
Increased coffee intake significantly decreases risk in nonalcoholic steatohepatitis patientsCaffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine c
-
'Goldilocks' Gene Could Determine Best Treatment for TB Patients
Sunday, February 5, 2012
Tuberculosis patients may receive treatments in the future according to what version they have of a single 'Goldilocks' gene, says an international research team from Oxford University, King's College London, Vietnam and the USAThis is one of the first examples in infectious disease of where an in
-
Sickle Cell Anemia Stroke Prevention Efforts May Have Decreased Racial Disparities
Sunday, February 5, 2012
The disparity in stroke-related deaths among black and white children dramatically narrowed after prevention strategies changed to include ultrasound screening and chronic blood transfusions for children with sickle cell anemia, according to research presented at the American Stroke Association's
-
Blood Test to Help Diagnose 2 Rare Genetic Diseases
Sunday, February 5, 2012
A newly available DNA-based prenatal blood test that can identify a pregnancy with Down syndrome can also identify two additional chromosome abnormalities: trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome).The test for all three defects can be offered as early as 10 weeks of pregnancy
-
Athersys Touts Results of Phase 1 Blood Diseases Trial
Sunday, February 5, 2012
Stem cell therapy developer Athersys (NASDAQ:ATHX) reported positive results from a phase 1 clinical trial in patients with leukemia and similar blood diseasesThe trial showed that the company’s MultiStem technology may reduce the incidence and severity of graft-versus-host disease, according to
-
Subcutaneous Adipose Tissue Fatty Acid Desaturation in Adults With and Without Rare Adipose Disorders
Sunday, February 5, 2012
Elevated stearoyl-CoA desaturase activity has been described in obese states, with an increased desaturation index (DI) suggesting enhanced lipogenesis. Differences in the DI among various phenotypes of abnormal adiposity have not been studiedAbnormal accumulation of subcutaneous adipose tissue oc
-
Experimental Drug Reduces 'Second Stroke' After Aneurysm Rupture
Sunday, February 5, 2012
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012
-
Gene Linked to Pancreatic Cancer Growth, U-M Study Finds
Sunday, February 5, 2012
Ann Arbor - A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers. The finding suggests a possible target for developing new